drugset / Trial / NCT07029932
A Phase 1 Study of the Safety and Tolerability of Single and Multiple Ascending Doses of BWC0977 in Healthy Volunteers
RandomizedSequentialDouble-blindTreatment
Summary
The purpose of this study is to assess the safety, tolerability and pharmacokinetics of single and multiple intravenous doses of BWC0977 when administered to healthy adult volunteers.
Timeline
- Start
- 2025-10-10
- Primary completion
- 2026-06-30
- Completion
- 2026-08-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | BWC0977 | Unknown | 750 mg | Intravenous |
| Subject | BWC0977 | Unknown | 1500 mg | Intravenous |